To ascertain whether FFX promotes mTORC1 signaling in cancer, we conducted Western blot analyses on two key mTORC1 substrates, p70S6K and 4E-BP1 (Figure 3F), in cell lines where FFX expression was either inhibited or enhanced. This evidence concerns the gene RPS6KB1 and cancer.